Anika Therapeutics (ANIK) EBIT Margin (QoQ) (2010 - 2026)
Anika Therapeutics (ANIK) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Anika Therapeutics | 281.13 Mn | 242.72 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,759.00 |
| Mar 31, 2026 | -2,064.00 |
| Dec 31, 2025 | 1,373.00 |
| Sep 30, 2025 | 319.00 |
| Jun 30, 2025 | 156.00 |
| Mar 31, 2025 | -1,407.00 |
| Dec 31, 2024 | -203.00 |
| Sep 30, 2024 | 562.00 |
| Jun 30, 2024 | 274.00 |
| Mar 31, 2024 | 84,346.00 |
| Dec 31, 2023 | -83,358.00 |
| Sep 30, 2023 | -1,031.00 |
| Jun 30, 2023 | 2,490.00 |
| Mar 31, 2023 | 55,545.00 |
| Dec 31, 2022 | -57,415.00 |
| Sep 30, 2022 | -587.00 |
| Jun 30, 2022 | 116.00 |
| Mar 31, 2022 | 1,578.00 |
| Dec 31, 2021 | -2,876.00 |
| Sep 30, 2021 | -2,078.00 |